Citalopram (Celexa)
A randomized, double-blind, placebo-controlled, pilot clinical trial in 20 people with HD between the ages of 18 and 60, to consider the efficacy of citalopram. The trial lasts about 21 weeks and requires eight outpatient visits and two telephone visits. Participants will be offered travel reimbursement and some compensation for participation.
Comparison will be made of executive function before and after treatment. Other assessments include cognitive and functional measures and brain imaging. The study is located at the University of Iowa, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS).
For more information about the trial, including who to contact:
Clinicaltrials.gov information